Neuroprotective effects of puerarin against beta-amyloid-induced neurotoxicity in PC12 cells via a PI3K-dependent signaling pathway. 2011

Guihua Xing, and Miaoxian Dong, and Xiaoming Li, and Yu Zou, and Li Fan, and Xiaoli Wang, and Defu Cai, and Chengchong Li, and Li Zhou, and Jicheng Liu, and Yingcai Niu
The Institute of Medicine, Qiqihar Medical University, 333 BuKui Street, JianHua District, Qiqihar 161042, China.

Epidemiological data have indicated that estrogen replacement therapy (ERT) can decrease the risk of developing Alzheimer's disease (AD). Phytoestrogens have been proposed as potential alternatives to ERT. The aim of the present study was to assess the neuroprotective effects of puerarin, a phytoestrogen isolated from Pueraria lobata, against the toxicity of beta-amyloid (Aβ) in relation to the mitochondria-mediated cell death process, and to elucidate the role the activation of Akt and modulation of the pro- and antiapoptotic proteins in puerarin-induced neuroprotection. The present study shows that puerarin afforded protection against Aβ-induced toxicity through inhibiting apoptosis in PC12 cells. This result was also confirmed by the activated caspase-3 assay. P-Akt, Bcl-2 and p-Bad expression increased after pretreatment with puerarin in PC12 cells exposed to Aβ(25-35), whereas Bax expression and cytochrome c release decreased. Interestingly, these effects of puerarin against Aβ(25-35) insult were abolished by wortmannin, an inhibitor of PI3K phosphorylation. These findings suggest that puerarin prevent Aβ-induced neurotoxicity through inhibiting neuronal apoptosis, and might be a potential preventive or therapeutic agent for AD.

UI MeSH Term Description Entries
D007529 Isoflavones 3-Phenylchromones. Isomeric form of FLAVONOIDS in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position. 3-Benzylchroman-4-One,3-Benzylidene-4-Chromanone,Homoisoflavone,Homoisoflavones,Isoflavone,Isoflavone Derivative,3-Benzylchroman-4-Ones,3-Benzylidene-4-Chromanones,Isoflavone Derivatives,3 Benzylchroman 4 One,3 Benzylchroman 4 Ones,3 Benzylidene 4 Chromanone,3 Benzylidene 4 Chromanones,Derivative, Isoflavone,Derivatives, Isoflavone
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Guihua Xing, and Miaoxian Dong, and Xiaoming Li, and Yu Zou, and Li Fan, and Xiaoli Wang, and Defu Cai, and Chengchong Li, and Li Zhou, and Jicheng Liu, and Yingcai Niu
July 2016, Neurochemistry international,
Guihua Xing, and Miaoxian Dong, and Xiaoming Li, and Yu Zou, and Li Fan, and Xiaoli Wang, and Defu Cai, and Chengchong Li, and Li Zhou, and Jicheng Liu, and Yingcai Niu
April 2016, Molecules (Basel, Switzerland),
Guihua Xing, and Miaoxian Dong, and Xiaoming Li, and Yu Zou, and Li Fan, and Xiaoli Wang, and Defu Cai, and Chengchong Li, and Li Zhou, and Jicheng Liu, and Yingcai Niu
January 2013, Evidence-based complementary and alternative medicine : eCAM,
Guihua Xing, and Miaoxian Dong, and Xiaoming Li, and Yu Zou, and Li Fan, and Xiaoli Wang, and Defu Cai, and Chengchong Li, and Li Zhou, and Jicheng Liu, and Yingcai Niu
November 2014, Neurochemical research,
Guihua Xing, and Miaoxian Dong, and Xiaoming Li, and Yu Zou, and Li Fan, and Xiaoli Wang, and Defu Cai, and Chengchong Li, and Li Zhou, and Jicheng Liu, and Yingcai Niu
April 2016, Neurological research,
Guihua Xing, and Miaoxian Dong, and Xiaoming Li, and Yu Zou, and Li Fan, and Xiaoli Wang, and Defu Cai, and Chengchong Li, and Li Zhou, and Jicheng Liu, and Yingcai Niu
March 2007, Neuroscience,
Guihua Xing, and Miaoxian Dong, and Xiaoming Li, and Yu Zou, and Li Fan, and Xiaoli Wang, and Defu Cai, and Chengchong Li, and Li Zhou, and Jicheng Liu, and Yingcai Niu
October 2008, Cell biology international,
Guihua Xing, and Miaoxian Dong, and Xiaoming Li, and Yu Zou, and Li Fan, and Xiaoli Wang, and Defu Cai, and Chengchong Li, and Li Zhou, and Jicheng Liu, and Yingcai Niu
January 2009, Neuropharmacology,
Guihua Xing, and Miaoxian Dong, and Xiaoming Li, and Yu Zou, and Li Fan, and Xiaoli Wang, and Defu Cai, and Chengchong Li, and Li Zhou, and Jicheng Liu, and Yingcai Niu
February 2012, Translational neurodegeneration,
Guihua Xing, and Miaoxian Dong, and Xiaoming Li, and Yu Zou, and Li Fan, and Xiaoli Wang, and Defu Cai, and Chengchong Li, and Li Zhou, and Jicheng Liu, and Yingcai Niu
January 2017, Alcohol and alcoholism (Oxford, Oxfordshire),
Copied contents to your clipboard!